Abstract: Various embodiments of the teachings herein include a computer-implemented method for generating a building automation project of a building automation system. The method may include: receiving structural information regarding building equipment; generating a semantic model of the building automation system, including automatically extracting equipment information from the structural information; extending the semantic model of the building automation system by providing application information; and generating, based on the equipment information and application information of the extended semantic model, a building automation project adapted for loading on a building automation device.

Abstract: A computer-implemented method automatically produces a test plan for measuring a measured object. The method includes obtaining a desired dataset of the measured object. The method includes providing a starting pattern. The providing comprises producing a division. The producing the division comprises applying at least one division function. The division has a plurality of division indices. The method includes producing a target pattern by generating a comparison between the desired dataset and the division. At least one division index is adapted in response to a deviation of the division from the desired dataset. The method includes creating at least one element with at least one piece of pattern information in the test plan in accordance with the target pattern.

Abstract: The present invention relates to the dosage and administration of anti-BCMA agents for the treatment of BCMA positive neoplasms. More specifically, the present invention relates to an antibody construct comprising a first domain which binds to BCMA, a second domain which binds to CD3 and a third domain which extends or enhances the half-life of the antibody construct, for use in the treatment or amelioration of a BCMA positive neoplasm, wherein the antibody construct is administered at a specified dose in at least one cycle. Moreover, the invention relates to a method for the treatment of a BCMA positive neoplasm comprising administering a specified dose of such antibody construct, and the use of such antibody construct for the manufacture of a medicament for the treatment of a BCMA positive neoplasm.

Abstract: A porous, silicate, ceramic body, optionally with different colors, with a first density, can be sintered into a silicate, ceramic body with a second density, wherein the ratio of the first density to the second density is 2/5 to 98/100, and the three-point bending strength of the porous, silicate ceramic body with a first density, measured according to ISO 6872, is 25 to 180 MPa.

Abstract: The present invention relates to a porous, silicate, ceramic body, possibly with different colors, with a first density, which can be sintered into a silicate, ceramic body with a second density, wherein the ratio of the first density to the second density is 2/5 to 98/100, and the three-point bending strength of the porous, silicate ceramic body with a first density, measured according to ISO 6872, amounts to 25 to 180 MPa.

Abstract: The present invention relates to a porous, silicate, ceramic body, possibly with different colors, with a first density, which can be sintered into a silicate, ceramic body with a second density, wherein the ratio of the first density to the second density is 2/5 to 98/100, and the three-point bending strength of the porous, silicate ceramic body with a first density, measured according to ISO 6872, amounts to 25 to 180 MPa.

Abstract: The present invention relates to a porous, silicate, ceramic body, possibly with different colors, with a first density, which can be sintered into a silicate, ceramic body with a second density, wherein the ratio of the first density to the second density is 2/5 to 98/100, and the three-point bending strength of the porous, silicate ceramic body with a first density, measured according to ISO 6872, amounts to 25 to 180 MPa.

Abstract: The present invention relates to a porous, silicate, ceramic body, possibly with different colors, with a first density, which can be sintered into a silicate, ceramic body with a second density, wherein the ratio of the first density to the second density is 2/5 to 98/100, and the three-point bending strength of the porous, silicate ceramic body with a first density, measured according to ISO 6872, amounts to 25 to 180 MPa.

Abstract: The present invention relates to a porous, silicate, ceramic body, possibly with different colors, with a first density, which can be sintered into a silicate, ceramic body with a second density, wherein the ratio of the first density to the second density is 2/5 to 98/100, and the three-point bending strength of the porous, silicate ceramic body with a first density, measured according to ISO 6872, amounts to 25 to 180 MPa.